Chronic Spontaneous Urticaria and Bruton Tyrosine Kinase: A Multispecialty Expert Discussion - Episode 4
BTK Inhibition as a Strategy for CSU Treatment
Published on:
Panelists discuss how Bruton tyrosine kinase (BTK) inhibition could effectively treat both autoallergic and autoimmune chronic spontaneous urticaria (CSU).
Video content above is prompted by the following:
• How would targeting BTK through inhibition be a strategy in the treatment of both IgE (autoallergic) and IgG (autoimmune) CSU?
• Covalent binding enables high and sustained occupancy of BTK without the need for sustained systemic exposure.
